Observational longitudinal study to assess the outcome of patients with idiopathic inflammatory myositis using validated tools.

IIM patients had good outcomes with the majority achieving remission and near-complete muscle recovery. However, the patients presenting late to the rheumatologists were more likely to have smoldering disease, more immunosuppressive medicines, and greater accumulated damage.